In conclusion, our agnostic investigation to identify risk factors for CAD strongly prioritized ApoB, suggesting that ApoB, representing the number of hepatic-derived lipoprotein particles, is the key determinant of CAD risk among lipid-related measurements. The gene discussed is APOB; the disease is coronary artery disorder.